Aldeyra Therapeutics, Inc.
FORMULATIONS FOR TREATMENT OF DRY EYE DISEASE
Last updated:
Abstract:
The present invention provides a reproxalap ophthalmic solution, and methods of using the same for treating dry eye disease.
Status:
Application
Type:
Utility
Filling date:
12 Oct 2021
Issue date:
5 May 2022